NCT00456924View on ClinicalTrials.gov

Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

December 31, 2004

Conditions

ContraceptionGynecologic Diseases

Interventions

DRUG

VA2914

Trial Locations (4)

Unknown

Liege University Hospital, Liège

Sainte Rosalie Clinique, Liège

Antoine Beclere Hospital, Clamart

Saint Antoine Hospital, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

HRA Pharma

INDUSTRY

NCT00456924 - Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914 | Biotech Hunter | Biotech Hunter